Showing results (801-810 of 2,464) with videos related to
Sort By:
Pageof 247
Purinergic Signalling|July 25, 2012
The role of P2Y(14) and other P2Y receptors in degranulation of human LAD2 mast cellsZhan-Guo Gao, Qiang Wei, M P Suresh Jayasekara, et al.Journal of Medicinal Chemistry|September 1, 1985
Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptorsK A Jacobson, K L Kirk, W L Padgett, et al.Intellectual and Developmental Disabilities|June 18, 2014
To ID or not to ID? Changes in classification rates of intellectual disability using DSM-5Aimilia Papazoglou, Lisa A Jacobson, Marie McCabe, et al.Current Atherosclerosis Reports|November 18, 2024
Statin-Associated Muscle Symptoms: Identification and Recommendations for ManagementKevin C Maki, Carol F Kirkpatrick, Mary Katherine Cheeley, et al.Current Protocols|May 11, 2024
Quantifying NF-κB Activation by Flow Cytometry of IκBα DegradationPraveen Krishna Veerasubramanian, Bruce A Jacobson, Fridrik J Karlsson, et al.Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence|September 15, 2023
Cognitive disengagement syndrome (sluggish cognitive tempo) and medical conditions: a systematic review and call for future researchJoseph W Fredrick, Lisa A Jacobson, Rachel K Peterson, et al.Purinergic Signalling|May 12, 2026
The long march towards testing the adenosine receptor agonism hypothesis for human cerebroprotection: The story of the A1R/A3R receptor agonist AST-004Theodore E Liston, William S Korinek, Kenneth A Jacobson, et al.The American Review of Respiratory Disease|May 1, 1985
Acute respiratory failure caused by primary pulmonary coccidioidomycosis. Two case reports and a review of the literatureR A Larsen, J A Jacobson, A H Morris, et al.Journal of Clinical Lipidology|December 20, 2014
National Lipid Association Annual Summary of Clinical Lipidology 2015Harold E Bays, Peter H Jones, W Virgil Brown, et al.Archives of Internal Medicine|November 28, 1994
Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Implications for rational empiric antibiotic therapyJ H Burack, J A Hahn, D Saint-Maurice, et al.Pageof 247